Form D · Pharmaceuticals

CANTEX PHARMACEUTICALS, INC.

Weston, FL · CIK 0001374961

Offering snapshot reported Apr 23, 2014 · SEC filing

Reported sold
$3.27M
Offering amount: $3.27M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 8, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.64M$3.27MFeb 19, 2013: $700,000.00Feb 19, 2013Oct 31, 2013: $2,270,225.00Oct 31, 2013Apr 23, 2014: $3,270,326.00Apr 23, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,270,225 → $3,270,326
  • Reported investors6 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 23, 2014Amendment$3,270,326$1,000,101vs Oct 31, 20137SEC filing
Oct 31, 2013Amendment$2,270,225$1,570,225vs Feb 19, 20136SEC filing
Feb 19, 2013Initial$700,000No comparison5SEC filing
Aug 4, 2010Initial$4,394,613No comparison4SEC filing
Aug 17, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Sep 5, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-192030

Source: Form D, filed Apr 23, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Claude Bertrand Executive
Todd C. Brady Director
Neil Flanzraich Director, Executive
Myles D. Greenberg Director
Christopher A. Kroeger Director
Stephen G. Marcus Director, Executive
Christopher Martin Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1792 Bell Tower Lane Suite 222
Weston, FL, 33326